National Partnership To Improve Dementia Care
Reductions in antipsychotic use in long-stay nursing home residents may reflect more residents being diagnosed with mental health conditions excluded from quality measurement audits, a new study suggests.
The percent of long-stay nursing home residents receiving antipsychotic medication has decreased 18.8% under a nationwide initiative that started in 2012.
After years of pushing, long-term care facilities have reduced their use of antipsychotic medication for dementia, according to an April report from the Centers for Medicare & Medicaid Services.
Long-term care facilities have reduced antipsychotic medication use by more than 15% through a large-scale initiative, according to a new report from the Centers for Medicare & Medicaid Services. That means it's time to set a more ambitious goal, a subgroup says.
For decades, many providers have viewed antipsychotic drugs as a necessary evil for treating residents with dementia. But increasingly, these medications are just being seen as evil. So it's hardly a surprise that the government and the long-term care field are praising notable progress toward reducing their use by 15%.